Boulder iQ Execs Discuss Ways to Speed Products to Market at LSI Emerging MedTech Summit

— Processes highlight single-source product development, sterilization, regulatory work —

BOULDER, Colo., March 17, 2025 /PRNewswire/ — Boulder iQ executives will be presenting novel ways for medical device developers to speed their products to market at this week’s LSI USA 25 Emerging MedTech Summit in Dana Point, California.

Jim Kasic, president and CEO, and Larry Blankenship, director, will attend the summit to discuss product design and development, sterilization, and regulatory affairs and quality assurance. Boulder iQ has developed unique, time- and cost-effective processes and techniques for device developers.

The summit, which connects medtech leaders with investors in a curated forum, will feature panel discussions and keynotes with current leaders in the industry, and extensive opportunities for individual meetings. Approximately 1,500 executives from emerging companies, venture capital and private equity firms, family offices, global strategics and professional service providers will attend.

Boulder iQ is an expert contract firm that provides life sciences companies the services they need to bring their products to market. Together with its sister companies, Boulder Sterilization, and Boulder Regulatory and Quality, Boulder iQ offers developers an efficient, proven way to speed product introduction with a “think smart” approach.

• Boulder iQ: ideation, conceptual R&D, usability engineering, prototyping, project planning, product and process development, verification and validation testing, design history file (DHF) and device master record (DMR) release
• Boulder Sterilization: quick-turn ethylene oxide and chlorine dioxide sterilization, final assembly and packaging services
• Boulder Regulatory Affairs and Quality Assurance: strategy, audits, FDA and EU submittals, FDA Q-Sub support, remediation, Quality Management System support, process validation and verification, risk management and gap analysis

To meet growing demand, Boulder iQ recently expanded its footprint in Boulder, Colorado, by almost 100%. The company will use the additional space for assembly, packaging and labeling. Product design, testing, rapid prototyping, cleanroom operations and sterilization will continue to take place at its current facility.

“Medical device companies recognize the benefits of our expertise and single-source capability,” says Kasic. He notes that Boulder iQ has significant contracts with clients in 33 states and 6 foreign countries. “Most of our clients are companies with which we’ve worked before, or are referred, but we are seeing greater interest across the board in our quick-turn sterilization services, and in the regulatory expertise we offer start-up companies.”

Boulder iQ (www.boulderiq.com)
Boulder iQ is an expert contract firm that provides life sciences companies all the services they need to bring products to market. Sister companies Boulder Sterilization, and Boulder Regulatory Affairs and Quality Assurance, work together to help developers speed products to market. Boulder Sterilization provides quick-turn ethylene oxide and chlorine dioxide sterilization, final assembly and packaging services. Boulder Regulatory Affairs and Quality Assurance provides full regulatory and quality support.

Based in Boulder, Colorado, Boulder iQ is ISO 13485:2016 certified through Boulder BioMed.

Media contact: Aimee Bennett, aimee@faganbusinesscommunications.com, 303-843-9840

View original content:https://www.prnewswire.com/news-releases/boulder-iq-execs-discuss-ways-to-speed-products-to-market-at-lsi-emerging-medtech-summit-302402484.html

SOURCE Boulder iQ